Safety and pharmacokinetics of liposomal curcumin in healthy subjects:A randomized placebo-controlled double blind first-in human study.

被引：0

作者：

Storka, Angela ^{[1
]}

Wolzt, Michael ^{[1
]}

Vcelar, Brigitta ^{[2
]}

Bolger, Gordon ^{[3
]}

Majeed, Muhammed ^{[4
]}

Helson, Lawrence ^{[5
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Polymun Sci GmbH, Vienna, Austria

[3] Nucro Tech Inc, Scarborough, ON, Canada

[4] Sabinsa Inc, East Windsor, NJ USA

[5] Sign Path Pharma, Quakertown, PA USA

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-LB-165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB165

引用

页数：1

共 50 条

[1] First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study
Shen, Qi
Hu, Chao
Miao, Jia
Chen, Junxia
Peng, Yueying
Pan, Tingting
He, Xiaolin
Yuan, Jing
Ni, Shaonan
Wang, Yongsheng
Luo, Zhu
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 159
[2] PHARMACOKINETICS OF LACOSAMIDE IN KOREAN HEALTHY SUBJECTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE AND REPEATED DOSE STUDY.
Gu, N.
Kim, B. H.
Lee, S.
Kim, T. E.
Fichtner, A.
Elshoff, J.
Yu, K. S.
King, I. J.
Shin, S. G.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S84 - S85
[3] The effect of propiverine on cardiac safety in healthy female subjects: A double-blind, placebo-controlled randomized study
Eckl, KM
Tsvitbaum, NM
Donath, F
Biletsky, SV
Sydorchuk, LP
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 262A - 262A
[4] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
Liu, Xiaoyan
Zhang, Rui
Li, Rong
Wu, Qiong
Pan, Chao
Yu, Xiangqing
Liu, Yuhui
Wang, Benjie
Yu, Shuwen
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
[5] A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects
Leubitz, Andi
Vanhoutte, Frederic
Hu, Ming-yi
Porter, Kaela
Gordon, Efrat
Tencer, Kathleen
Campbell, Kathleen
Banks, Kate
Haverty, Tom
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (08): : 859 - 869
[6] Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
Huang, Kai
Ding, Ying
Que, Linling
Chu, Nannan
Shi, Yunfei
Qian, Zhenzhong
Qin, Wei
Chen, Yuanxin
Gu, Xianghong
Wang, Jiakun
Zhang, Zhiwei
Xu, Jianguo
He, Qing
FRONTIERS IN PHARMACOLOGY, 2022, 13
[7] First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study
Hongzhong Liu
Qian Zhao
Yuping Yuan
Zhenlei Wang
Teng Wang
Wei Tian
Wen Zhong
Ji Jiang
Shuai Chen
Kai Kong
Chunyan Jin
Pei Hu
Infectious Diseases and Therapy, 2024, 13 : 361 - 371
[8] First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study
Liu, Hongzhong
Zhao, Qian
Yuan, Yuping
Wang, Zhenlei
Wang, Teng
Tian, Wei
Zhong, Wen
Jiang, Ji
Chen, Shuai
Kong, Kai
Jin, Chunyan
Hu, Pei
INFECTIOUS DISEASES AND THERAPY, 2024, 13 (02) : 361 - 371
[9] Safety and tolerability of Ganoderma lucidum in healthy subjects:: A double-blind randomized placebo-controlled trial
Wicks, Sheila M.
Tong, Robin
Wang, Chong-Zhi
O'Connor, Michael
Karrison, Theodore
Li, Shang
Moss, Jonathan
Yuan, Chun-Su
AMERICAN JOURNAL OF CHINESE MEDICINE, 2007, 35 (03): : 407 - 414
[10] Human Safety and Pharmacokinetics Study of Orally Administered Icariin: Randomized, Double-Blind, Placebo-Controlled Trial
Brown, E. Sherwood
Bice, Collette
Putnam, William C.
Leff, Richard
Kulikova, Alexandra
Nakamura, Alyson
Ivleva, Elena I.
Enkevort, Erin Van
Holmes, Traci
Miingi, Nyokabi
NATURAL PRODUCT COMMUNICATIONS, 2019, 14 (06)

← 1 2 3 4 5 →